我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
0
0 进行中
药物批准
批准总数
监管机构
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无批准数据
- ECU Health performed the first pacemaker implantation using Elutia's FDA-approved EluPro BioEnvelope, designed to prevent post-operative complications. - The EluPro BioEnvelope is the first antibiotic-eluting device for Cardiac Implantable Electronic Devices (CIEDs), addressing infection risks in vulnerable patients. - This advancement aims to improve patient outcomes and reduce complications associated with traditional pacemaker implantation procedures, especially for those with comorbidities. - The procedure highlights ECU Health's commitment to providing advanced cardiovascular care and reducing health disparities in eastern North Carolina.